Healthcare -
Biotechnology - NASDAQ - US
$ 5.16
-2.27 %
$ 46 M
Market Cap
-19.85
P/E
ICCC - OPERATING EXPENSES
Operating Expenses ICCC - ImmuCell Corporation
10.1 M
LAST VALUE
9.90%
2 YEAR CAGR
6.68%
5 YEAR CAGR
12.66%
10 YEAR CAGR